|
|
|
Insider
Information: |
Winningham Rick E |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,686,408 |
|
Indirect Shares
|
96,467 |
|
|
Direct
Value |
$32,096,465 |
|
|
Indirect Value
|
$926,083 |
|
|
Total
Shares |
2,782,875 |
|
|
Total
Value |
$33,022,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2013-04-30 |
4 |
AS |
$33.64 |
$8,597,169 |
D/D |
(255,532) |
721,551 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-04-17 |
4 |
AS |
$140.00 |
$3,850,000 |
D/D |
(27,500) |
13,587 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2013-04-30 |
4 |
OE |
$9.69 |
$3,731,247 |
D/D |
385,161 |
977,083 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-22 |
4 |
AS |
$21.43 |
$3,624,800 |
D/D |
(168,800) |
511,373 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-09 |
4 |
S |
$176.03 |
$2,814,838 |
D/D |
(15,979) |
5,610 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-02-20 |
4 |
D |
$25.90 |
$2,508,415 |
D/D |
(96,850) |
1,315,605 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-22 |
4 |
OE |
$8.53 |
$2,200,644 |
D/D |
258,140 |
680,173 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2012-08-03 |
4 |
AS |
$27.77 |
$2,117,306 |
D/D |
(75,749) |
591,258 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2021-02-20 |
4 |
D |
$18.79 |
$2,073,439 |
D/D |
(110,348) |
1,334,821 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-25 |
4 |
AS |
$22.22 |
$2,070,524 |
D/D |
(92,200) |
642,773 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-23 |
4 |
AS |
$21.14 |
$2,063,264 |
D/D |
(97,600) |
556,273 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-24 |
4 |
AS |
$21.45 |
$1,996,995 |
D/D |
(93,100) |
599,123 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-05-11 |
4 |
AS |
$26.28 |
$1,921,068 |
D/D |
(73,100) |
485,906 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$1,643,769 |
D/D |
(67,617) |
919,620 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-28 |
4 |
AS |
$22.49 |
$1,544,030 |
D/D |
(67,000) |
677,525 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-05-10 |
4 |
AS |
$26.41 |
$1,443,201 |
D/D |
(54,646) |
559,006 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-03-01 |
4 |
AS |
$22.53 |
$1,439,059 |
D/D |
(63,873) |
613,652 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2014-05-09 |
4 |
D |
$26.86 |
$1,349,044 |
D/D |
(50,225) |
703,038 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-23 |
4 |
OE |
$8.53 |
$1,214,813 |
D/D |
142,500 |
653,873 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-24 |
4 |
OE |
$8.53 |
$1,158,974 |
D/D |
135,950 |
692,223 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-25 |
4 |
OE |
$8.53 |
$1,158,121 |
D/D |
135,850 |
734,973 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-02-20 |
4 |
D |
$33.78 |
$1,123,658 |
D/D |
(33,264) |
870,135 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2013-09-12 |
4 |
AS |
$40.03 |
$894,791 |
D/D |
(22,353) |
690,106 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-28 |
4 |
OE |
$8.53 |
$867,436 |
D/D |
101,752 |
744,525 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2012-01-11 |
4 |
OE |
$8.23 |
$842,950 |
D/D |
55,000 |
46,656 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|